These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 1881946

  • 1. Verapamil and the synthesis of prostacyclin in human veins.
    Fahr A, Langer R, Sziegoleit W, Blauschmidt J, Albert H, Liebal H, Mest HJ.
    Pharmazie; 1991 Mar; 46(3):213-4. PubMed ID: 1881946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo.
    Strano A, Davì G, Novo S, Custro N, Mattina A, Gallo V.
    Int Angiol; 1985 Mar; 4(3):379-82. PubMed ID: 3913716
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R, Puri V, Srimal RC, Dhawan BN.
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D, Currie MG, Mollace V.
    J Clin Invest; 1996 Jun 01; 97(11):2562-8. PubMed ID: 8647949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Influence of the venous wall--platelet interaction by dihydroergotamine (author's transl)].
    Silberbauer K, Fitscha P, Sinzinger H.
    Wien Klin Wochenschr; 1981 Oct 02; 93(18):577-9. PubMed ID: 7029927
    [Abstract] [Full Text] [Related]

  • 14. Failure of salicylate to reduce inhibition of human venous prostacyclin in synthesis by conventional dose aspirin.
    Hanley SP, Hughes J.
    Thromb Haemost; 1983 Feb 28; 49(1):51-2. PubMed ID: 6342201
    [Abstract] [Full Text] [Related]

  • 15. Enhanced prostacyclin formation in veins of women under chronical treatment with oral contraceptive drugs.
    Sinzinger H, Klein K, Kaliman J, Silberbauer K, Feigl W.
    Pharmacol Res Commun; 1980 Jun 28; 12(6):515-21. PubMed ID: 6995996
    [Abstract] [Full Text] [Related]

  • 16. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P, Colli S, Sirtori C, Tremoli E, Paoletti R.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jun 28; 13():363-9. PubMed ID: 2408447
    [Abstract] [Full Text] [Related]

  • 17. Changes in platelet response to adenosine 5'-diphosphate caused by verapamil.
    Walkowiak B, Koziołkiewicz W, Michalec L, Pawłowska Z, Krzesłowska J, Cierniewski CS.
    Pol J Pharmacol; 1996 Jun 28; 48(3):303-5. PubMed ID: 9112667
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
    Leithner C, Winter M, Silbauer K, Wagner O, Pinggera W, Sinzinger H.
    Proc Eur Dial Transplant Assoc; 1978 Jun 28; 15():418-23. PubMed ID: 368786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.